Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group

doi:10.1016/S2666-5247(23)00344-0

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group

Research output: Contribution to journal › Comment/debate

245 Scopus citations

Original language	English
Pages (from-to)	e100-e101
Journal	The Lancet Microbe
Volume	5
Issue number	2
DOIs	https://doi.org/10.1016/S2666-5247(23)00344-0
State	Published - Feb 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S2666-5247(23)00344-0

Cite this

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group (2024). Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. The Lancet Microbe, 5(2), e100-e101. https://doi.org/10.1016/S2666-5247(23)00344-0

@article{89d2ca6949da4b59b7eecfd3919e9e22,

title = "Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions",

author = "\{European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group\} and \{Meyer Sauteur\}, \{Patrick M.\} and Beeton, \{Michael L.\} and Sabine Pereyre and C{\'e}cile B{\'e}b{\'e}ar and Marie Gardette and Nad{\`e}ge H{\'e}nin and No{\'e}mie Wagner and Adrien Fischer and Alessandra Vitale and Baptiste Lemaire and Gilbert Greub and Ren{\'e} Brouillet and Petra Zimmermann and Agyeman, \{Philipp KA\} and Christoph Aebi and Michael Buettcher and Marisa Hostettler and Lisa Kottanattu and Valeria Gaia and Frank Imkamp and Adrian Egli and Christoph Berger and Semjon Sidorov and Ester Osuna and Romy Tilen and Anita Niederer-Loher and G{\"u}nter Dollenmaier and Florence Barbey and Ulrich Heininger and Daniel Goldenberger and Branislav Ivan and Keller, \{Peter M.\} and Cihan Papan and Becker, \{S{\"o}ren L.\} and Johannes Forster and MacKenzie, \{Colin R.\} and Birgit Henrich and Melissa Vermeulen and Nathalie Bossuyt and Veerle Matheeussen and \{van Westreenen\}, Mireille and Marius Vogel and \{van Rossum\}, \{Annemarie MC\} and Baharak Afshar and Simon Cottrell and Catherine Moore and Uldum, \{S{\o}ren Anker\} and Emborg, \{Hanne Dorthe\} and Karolina Gullsby and Ran Nir-Paz",

year = "2024",

month = feb,

doi = "10.1016/S2666-5247(23)00344-0",

language = "אנגלית",

volume = "5",

pages = "e100--e101",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd.",

number = "2",

}

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group 2024, 'Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions', The Lancet Microbe, vol. 5, no. 2, pp. e100-e101. https://doi.org/10.1016/S2666-5247(23)00344-0

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. / European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group.
In: The Lancet Microbe, Vol. 5, No. 2, 02.2024, p. e100-e101.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Mycoplasma pneumoniae

T2 - delayed re-emergence after COVID-19 pandemic restrictions

AU - European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group

AU - Meyer Sauteur, Patrick M.

AU - Beeton, Michael L.

AU - Pereyre, Sabine

AU - Bébéar, Cécile

AU - Gardette, Marie

AU - Hénin, Nadège

AU - Wagner, Noémie

AU - Fischer, Adrien

AU - Vitale, Alessandra

AU - Lemaire, Baptiste

AU - Greub, Gilbert

AU - Brouillet, René

AU - Zimmermann, Petra

AU - Agyeman, Philipp KA

AU - Aebi, Christoph

AU - Buettcher, Michael

AU - Hostettler, Marisa

AU - Kottanattu, Lisa

AU - Gaia, Valeria

AU - Imkamp, Frank

AU - Egli, Adrian

AU - Berger, Christoph

AU - Sidorov, Semjon

AU - Osuna, Ester

AU - Tilen, Romy

AU - Niederer-Loher, Anita

AU - Dollenmaier, Günter

AU - Barbey, Florence

AU - Heininger, Ulrich

AU - Goldenberger, Daniel

AU - Ivan, Branislav

AU - Keller, Peter M.

AU - Papan, Cihan

AU - Becker, Sören L.

AU - Forster, Johannes

AU - MacKenzie, Colin R.

AU - Henrich, Birgit

AU - Vermeulen, Melissa

AU - Bossuyt, Nathalie

AU - Matheeussen, Veerle

AU - van Westreenen, Mireille

AU - Vogel, Marius

AU - van Rossum, Annemarie MC

AU - Afshar, Baharak

AU - Cottrell, Simon

AU - Moore, Catherine

AU - Uldum, Søren Anker

AU - Emborg, Hanne Dorthe

AU - Gullsby, Karolina

AU - Nir-Paz, Ran

PY - 2024/2

Y1 - 2024/2

UR - https://www.scopus.com/pages/publications/85179682628

U2 - 10.1016/S2666-5247(23)00344-0

DO - 10.1016/S2666-5247(23)00344-0

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:85179682628

SN - 2666-5247

VL - 5

SP - e100-e101

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 2

ER -

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

UN SDGs

Access to Document

Other files and links

Cite this